ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
ZYNE
Delisted
ZYNE was delisted on the 10th of October, 2023.
43 hedge funds and large institutions have $14.7M invested in Zynerba Pharmaceuticals, Inc in 2023 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 3 increasing their positions, 11 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
73% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 11
Holders
43
Holding in Top 10
–
Calls
$45K
Puts
$27K
Top Buyers
| 1 | +$6.25M | |
| 2 | +$2.91M | |
| 3 | +$791K | |
| 4 |
CL
CSS LLC
Chicago,
Illinois
|
+$608K |
| 5 |
DAM
Deltec Asset Management
New York
|
+$606K |
Top Sellers
| 1 | -$711K | |
| 2 | -$444K | |
| 3 | -$241K | |
| 4 |
Renaissance Technologies
New York
|
-$107K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$93.7K |